<code id='32CE022A01'></code><style id='32CE022A01'></style>
    • <acronym id='32CE022A01'></acronym>
      <center id='32CE022A01'><center id='32CE022A01'><tfoot id='32CE022A01'></tfoot></center><abbr id='32CE022A01'><dir id='32CE022A01'><tfoot id='32CE022A01'></tfoot><noframes id='32CE022A01'>

    • <optgroup id='32CE022A01'><strike id='32CE022A01'><sup id='32CE022A01'></sup></strike><code id='32CE022A01'></code></optgroup>
        1. <b id='32CE022A01'><label id='32CE022A01'><select id='32CE022A01'><dt id='32CE022A01'><span id='32CE022A01'></span></dt></select></label></b><u id='32CE022A01'></u>
          <i id='32CE022A01'><strike id='32CE022A01'><tt id='32CE022A01'><pre id='32CE022A01'></pre></tt></strike></i>

          explore

          explore

          author:fashion    Page View:442
          Sammy Kimball for STAT

          Is Wegovy really a brain drug? Which Alzheimer’s disease treatment works best? And what’s the point of Threads?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Megan Molteni joins us to explain the evolving science suggesting products like Wegovy are less weight loss drugs than treatments for human desire. We also explain why this summer is shaping up to be a pivotal moment for the treatment of Alzheimer’s and discuss our befuddlement with the latest social media platform.

          advertisement

          For more on what we cover, here’s the story on GLP-1 drugs and the brain; here’s the latest on Leqembi; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          leisure time

          New air purifier tech could be key to improving indoor air quality
          New air purifier tech could be key to improving indoor air quality

          AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

          read more
          Ultragenyx gene therapy for rare liver ailment succeeds in late
          Ultragenyx gene therapy for rare liver ailment succeeds in late

          JonathanWiggs/GlobeStaffUltragenyxsaidThursdayafternoonthatitsgenetherapyforarareliverailment,glycog

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          Letters to First Opinion on caregivers, digital health, and more

          MollyFergusonforSTATToencouragerobust,good-faithdiscussionaboutissuesraisedinFirstOpinion,STATpublis